Table 3.
Univariate logistic regression of baseline parameters associated with CBD dilatation
| Parameter | CBD dilatation (%) | Odds Ratio | 95% Confidence Limit | P value |
|---|---|---|---|---|
| Age | - | 1 | 1.01–1.08 | 0.006 |
| IPMN diagnosis | 29.1 | 3.8 | 1.3–11.5 | 0.01 |
| Gender Male vs. Female | 14.9/30.8 | 0.4 | 0.18–0.9 | 0.02 |
| Family history of pancreatic cancer | 50 | 1.34 | 0.15–11.76 | 0.79 |
| Background liver disease | 33.3 | 1.77 | 0.32–9.81 | 0.51 |
| Personal history of cancer | 37 | 2.18 | 0.9–5.27 | 0.08 |
| Smoking | 12.5 | 0.6 | 0.09–4.03 | 0.6 |
| Alcohol | 0 | 0.44 | 0.01–13.61 | 0.64 |
| Gallbladder stone by EUS | 30.8 | 1.54 | 0.61–3.88 | 0.36 |
| Resected gallbladder | 60.7 | 7.75 | 3.19–18.84 | < 0.001 |